We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.65B
AUM Growth
+$158M
Cap. Flow
-$37.9M
Cap. Flow %
-2.29%
Top 10 Hldgs %
48.4%
Holding
142
New
11
Increased
37
Reduced
35
Closed
5

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$15.6M
2
CRM icon
Salesforce
CRM
+$3.28M
3
DKNG icon
DraftKings
DKNG
+$3.2M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.24M
5
META icon
Meta Platforms (Facebook)
META
+$2.11M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10M
3
CI icon
Cigna
CI
+$9.59M
4
IBM icon
IBM
IBM
+$7.63M
5
NTAP icon
NetApp
NTAP
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 38.78%
2 Communication Services 14.27%
3 Healthcare 14.18%
4 Consumer Discretionary 14.17%
5 Financials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AIZ icon
51
Assurant
AIZ
$14B
$6.04M 0.37%
44,350
– –
PAYX icon
52
Paychex
PAYX
$41.4B
$5.51M 0.33%
59,160
-375
-0.6% -$33.3K
BNY
53
Bank of New York Mellon
BNY
$106B
$5.5M 0.33%
129,525
– –
SEDG icon
54
SolarEdge
SEDG
$2.54B
$5.3M 0.32%
16,600
-890
-5% -$246K
BIIB icon
55
Biogen
BIIB
$30.7B
$4.23M 0.26%
17,273
– –
DGX icon
56
Quest Diagnostics
DGX
$25.9B
$3.66M 0.22%
30,700
– –
CRL icon
57
Charles River Laboratories
CRL
$11.3B
$3.49M 0.21%
13,965
– –
IBM icon
58
IBM
IBM
$209B
$3.47M 0.21%
28,851
-66,001
-70% -$7.63M
COHU icon
59
Cohu
COHU
$2.19B
$3.4M 0.21%
88,911
-14,725
-14% -$402K
UTHR icon
60
United Therapeutics
UTHR
$26.2B
$3.32M 0.2%
21,885
– –
UNH icon
61
UnitedHealth
UNH
$383B
$3.24M 0.2%
9,250
– –
CI icon
62
Cigna
CI
$76.1B
$3.17M 0.19%
15,230
-48,920
-76% -$9.59M
AMBA icon
63
Ambarella
AMBA
$3.25B
$2.95M 0.18%
32,110
+3,360
+12% +$235K
JKHY icon
64
Jack Henry & Associates
JKHY
$11B
$2.58M 0.16%
15,915
– –
AEIS icon
65
Advanced Energy
AEIS
$11B
$2.56M 0.15%
26,405
-575
-2% -$48.9K
TSLA icon
66
Tesla
TSLA
$1.22T
$2.56M 0.15%
10,875
-600
-5% -$102K
EG icon
67
Everest Group
EG
$14.9B
$2.48M 0.15%
10,600
– –
KLIC icon
68
Kulicke & Soffa
KLIC
$4.62B
$2.45M 0.15%
77,140
– –
UI icon
69
Ubiquiti
UI
$32.3B
$2.42M 0.15%
8,685
– –
CRUS icon
70
Cirrus Logic
CRUS
$6.65B
$2.34M 0.14%
28,440
+1,200
+4% +$90.2K
DIOD icon
71
Diodes
DIOD
$3.77B
$2.3M 0.14%
32,640
– –
ELV icon
72
Elevance Health
ELV
$81.6B
$2.3M 0.14%
7,155
– –
SYK icon
73
Stryker
SYK
$133B
$2.26M 0.14%
9,210
+1,000
+12% +$227K
NXGN
74
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$2.25M 0.14%
123,210
– –
JAZZ icon
75
Jazz Pharmaceuticals
JAZZ
$16.2B
$2.14M 0.13%
12,950
+9,295
+254% +$1.38M
1 2
3
4 5

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Oak Associates held 142 positions worth $1.65B, up 11% from $1.5B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Oak Associates's Q4 2020 filing shows 11 new, 37 increased, 35 reduced and 5 closed positions. Its largest new stake was Exelixis: 96,090 shares worth $1.93M. The largest sale was Gilead Sciences, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q4 2020 buy was Exelixis: 96,090 shares worth $1.93M.
  • Oak Associates added most to JPMorgan Chase in Q4 2020, an estimated $15.6M increase.
  • Oak Associates's biggest Q4 2020 reduction was Gilead Sciences, cutting an estimated $10.9M.
  • Oak Associates fully exited Juniper Networks in Q4 2020, selling an estimated $1.17M.
  • Oak Associates's ten largest holdings make up 48% of its $1.65B portfolio in Q4 2020.
  • Oak Associates opened 11 new positions and closed 5 in Q4 2020.
  • Oak Associates's portfolio value rose 11% quarter-over-quarter to $1.65B.

Based on Oak Associates's 13F filing for Q4 2020, filed 12 Feb 2021.